glenmark pharma share price

Glenmark Pharma soars as its arm receives USFDA’s approval for Lacosamide Tablets

by
glenmark pharmas arm receives usfdas approval for fulvestrant injection

Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at Rs. 445.00 and has touched a high and low of Rs. 457.85 and Rs. 445.00 respectively. So far 42623 shares were traded on the counter. The BSE … Read more

Glenmark Pharma’s arm gets USFDA’s nod for Bisoprolol Fumarate and Hydrochlorothiazide Tablets

by
glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (USFDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, the generic version of Ziac Tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, … Read more